ACM BIOLABS
ACM Biolabs focuses on developing novel vaccines and antibodies using proprietary artificial cell membrane ("ACM"​) technology. ACM is able to incorporate functional, folded membrane proteins into the artificial cell membranes which keeps them stable, allowing them to induce a strong immune reaction. ACM has demonstrated efficacy via both injected and oral dosages using synthesized membrane proteins and has a growing pipeline of vaccines and antibodies. The company is headquartered in Singapore, and has been operational since 2013.
ACM BIOLABS
Social Links:
Industry:
Alternative Medicine Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.acmbiolabs.com
Total Employee:
11+
Status:
Active
Contact:
+65 6265 5646
Email Addresses:
[email protected]
Total Funding:
6.8 M USD
Technology used in webpage:
GoDaddy European Commission Online Dispute Resolution
Similar Organizations
AS Medical support
AS Medical Support is a biotechnology firm that makes regenerative medicine and promotes the introduction of cell culture technologies.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Trans Chromosomics
Trans Chromosomics is a people's living and health by applying innovative chromosome engineering technology developed.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ritz Venture Capital
Ritz Venture Capital investment in Venture Round - ACM Biolabs
Official Site Inspections
http://www.acmbiolabs.com Semrush global rank: 5.63 M Semrush visits lastest month: 1.28 K
- Host name: 150.27.62.166.host.secureserver.net
- IP address: 166.62.27.150
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ACM Biolabs"
Home - ACM Biolabs
Anivind Kaur Bindra is a Scientist at ACM Biolabs. She obtained bachelor’s and master’s degrees in Chemistry from University of Delhi, India in 2015. Thereafter, from her research internship at Defence Research and Development …See details»
ACM Biolabs - Crunchbase Company Profile & Funding
Organization. ACM Biolabs . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
ACM Biolabs Company Profile 2024: Valuation, Funding …
Www.acmbiolabs.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 71 Nanyang Drive; Suite 02M-02 NTU Innovation Centre; Singapore, 638075; SingaporeSee details»
ACM Biosciences AG – Swiss Biotech
ACM Biosciences AG is a subsidiary of ACM Biolabs PTE Ltd. Singapore. Its purpose is to internationalise its development activities. It leads all clinical and regulatory activities of its …See details»
ACM Biolabs - VentureRadar
"Founded in Singapore in 2013, ACM Biolabs has established laboratories for research and early manufacturing activities. ACM Biolabs is well connected in the academic and biotechnology …See details»
ACM Biolabs - LinkedIn
Madhavan Nallani, CEO at ACM Biolabs will present at our first Asian Delivery & Formulation Summit this year. About Madhavan Nallani, Madhavan obtained his PhD at Jacobs University Bremen, Germany ...See details»
ACM Biolabs - Overview, News & Similar companies - ZoomInfo
Sep 4, 2023 Who is ACM Biolabs. Biosciences ACM Biosciences was incorporated in Basel, Switzerland, in 2020 as the human infectious disease vaccine company of ACM Biolabs, which …See details»
Company Archives - ACM Biolabs
Jul 29, 2022 ACM Biolabs shines at NTUitive’s Technology Roadshow 2023 “ACM Biolabs is just one of 70 deep-tech firms spun off from Nanyang Technological University (NTU) research …See details»
ACM Biolabs - LinkedIn
I will be presenting at the The World Vaccine Congress Washington, the World’s leading vaccine event, next week! On Wednesday, the 2nd day of the congress, I'll be discussing ACM …See details»
ACM Biosciences closes first financing round to accelerate the ...
Basel, 7 April 2021 – ACM Biosciences AG, a Swiss biotechnology company focusing on the development of polymersome-based vaccines, today announced the closing of a first financing …See details»
ACM Biolabs - Products, Competitors, Financials, Employees ...
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001. Sep 5, 2023. USA - English Share this article Provides clinical validation …See details»
ACM Biolabs Announces Positive Topline Results from a Phase
Sep 5, 2023 Provides clinical validation for ACM Biolab's Tunable Platform ("ATPâ„¢"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the …See details»
As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, …
Jul 29, 2022 SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM Biolabs, a biotechnology company with operations in Singapore, Switzerland and …See details»
News Archives - ACM Biolabs
Sep 5, 2023 [email protected]. Download this post as PDF. Newspost | 14.04.2023 We are delighted to announce the appointment of David Lawrence as Non …See details»
ACM Biolabs Announces Positive Topline Results from a Phase
Sep 5, 2023 ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, …See details»
ACM Biolabs Announces Positive Topline Results from a Phase I …
Sep 5, 2023 Provides clinical validation for ACM Biolab's Tunable Platform ("ATPâ„¢"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the …See details»
ACM Biolabs’ intranasal COVID vaccine presents excellent …
Mar 4, 2022 For further information, please visit: www.acmbiolabs.com. Disclaimer . This press release contains forward-looking statements which are based on current assumptions and …See details»
ACM Biolabs Announces Positive Topline Results from a Phase I …
Sep 5, 2023 The Company has a growing pipeline of discovery and development-stage product formulations targeting numerous therapeutic areas including infectious diseases, oncology, …See details»
ACM Biolabs Announces Positive Topline Results from a Phase I …
Sep 5, 2023 Singapore, Basel and Sydney, 5 September 2023 – ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano …See details»
News - ACM Biolabs
Apr 14, 2023 ACM Biolabs is focused at developing novel vaccines and antibodies using their proprietary artificial cell membrane - ACM technology. Incorporate functional, folded …See details»